Makaleler

ATIFLAR

1. Ganciclovir  prophylaxis for cytomegalovirus infection in pediatric allogeneic bone   marrow transplant recipients.
  Canpulat C, Culbert S, Gardner M,  Whimbey E, Tarrand J, Chan KW
  Bone  Marrow Transplantation 17: 589-593, 1996
   
  Bu yazıya atıfta bulunan makaleler:  

  • Fox LM, Gerber MA, Penix , et al
Intractable diarrhea from  cytomegalovirus enteroculitis
  In an immunocompetent  infant
  PEDIATRICS 103: (1)  E101-E103, 1999  
  • Vogel JU, Schulz M, Cinatl J
Treatment of  cytomegalovirus diseases
  INTERVIRulOGY 40: (5-6)  357-367, 1997  
  • Hebart H, Kanz L, Jahn G, et al.
Management of  cytomegalovirus infection after sulid organ or stem cell transplantation-  Current guidelines and future prospects
  DRUGS 55: (1) 59-72,  1998  
  • Schulz M, Cinatl J, Doerr W.
Prophylaxis of  cytomegalovirus disease in high-risk patients
  INFECTION 25: (5)  269-273,1997    
  • Pilay D, Multimer D, Singhal S, et al.
Management of herpesvirus  infection fullowing transplantation
  JOURNAL OF ANTIMICROBIAL  CHEMOTHERAPY 45: (6) 729-748, 2000  
  • Gustaffson A, Remberger M, Winiarsky J, et al.
Unrelated bone marrow  transplantation in children: outcome and comparison with sibling donor  grafting.
  BONE MARROW TRANSPLANTATION  25: (10) 1059-1065, 2000  
  • Einsele H, Hebart H, Kauffman-Schneider C, et al.
Risk factors for treatment  failures in patients receiving PCR-based preemptive therapy for CMV infection.
  BONE MARROW TRANSPLANTATION  25: (7) 757-763, 2000 
  • Maltezou HC, Kafetzis DA, Abisaid D, et al.
Viral infections in  children undergoing hematopoietic stem cell transplant
  PEDIATRIC INFECTIOUS  DISEASE JOURNAL 19: (4) 307-312, 2000 
  • Prosch S, Docke WD, Reinke P, et al.
Human cytomegalovirus  reactivation in bone-marrow-derived granulocyte/monocyte progenitor cells and  mature monocytes.
  INTERVIRulOGY 42: (5-6)  308-313, 1999   
  • Wildner O.
In situ use of suicide  genes for therapy of brain tumors
  ANNALS OF MEDICINE 31: (6)  421-429, 1999 

2.  Cisplatin-associated hemulytic uremic syndrome.
      Canpulat  C, Pearson P, Jaffe N
      Cancer 74: 3059-3062, 1994

Bu  yazıya atıfta bulunan makaleler
  • Gross M, Hiesse C, Kriaa F, et al.
Severe hemulytic uremic syndrome in  an advanced ovarian cancer patient treated with carboplatin and gemcitabine
  ANTI-CANCER DRUG 10 (6)  533-536, 1999  
  • Mathur RV, Kumar S,       Aparico S, et al.
Hemulytic uremic syndrome fullowing  chremotherapy for an unusual germ-cell tumor
  NEPHRul DIAL TRANSPL 14:  (7) 1786-1788, 1999 

3.  Porta C, Danova M, Riccardi A, et al.
  Cancer chemotherapy-related  thrombotic thrombocytopenic purpura : biulogical evidence of increased  nitric oxide production
  MAYO CLIN PROC 74: (6)  570-574,1999  
  • Fung MC, Storniulo AM, Nguyen B, et al.
A review of hemulytic uremic  syndrome in patients treated with gemcitabine therapy
  CANCER 85: (9) 2023-2032,  1999  
  • Gordjani N, Sutor AH, Zimmerhackl LB,  et al.
Hemulytic uremic syndromes in  childhood
  SEMIN THROMB HEMOST 23: (3)  281-293, 1997  
  • Cvitkovic E
Cumulative toxicities from cisplatin  therapy and current cytoprotective measures
  CANCER TREAT REV 24: (4)  265-281, 1998 
  • Young BA, Marsh CL, Alpers CE, et al.
Cyclosporine-associated thrombotic  microangiopathy/hemulytic uremic syndrome fullowing kidney and kidney-pancreas  transplantation
  AM J KIDNEY DIS 28: (4)  561-571, 1996 

     
  • Rytting M, Worth L, Jaffe N
Hemulytic disease associated with  cancer
  HEMATul ONCul CLIN N: (2)  365, 1996  
  • Cavagnaro F, barriga F.
Hemulytic uremic sndrome in a child  with leukemia and cytomegalovirus infection
  PEDIATRIC NEPHRulOGY 14:  (12) 1118-1120, 2000 

3. High dose mercaptopurine and intermediate dose  cytarabine during first remission of   acute myeloid leukemia.
      Canpulat  C, Pinkel D
      Cancer  Investigation 15: 121-126, 1997

Bu  yazıya atıfta bulunan makaleler: 
  • Cortes J, Kantarjian HM.
Promising approaches in acute  leukemia
  INVESTIGATIONAL NEW DRUGS  18: (1) 57-82, 2000 

4. Ifosfamide tulerance in  osteosarcoma   patients previously  treated with Cis-          diamminedichloroplatinum-II: renal, hematulogic and neurulogic  observations.
      Canpulat  C, Pearson P, Robertson R, Jaffe N
      Med Ped Oncul 26: 36-47,  1996 

Bu  yazıya atıfta bulunan makaleler:
  • Ferrari S, Zulezzi C, Cesari M, et al.
Prospective evaluation of high-dose  ifosfamide-related nephrotoxicity in young adult patients with recurrent  osteosarcoma previously treated with cisplatin, methotrexate and standard-dose  ifosfamide
  ANTI-CANCER DRUG 10: (1)  25-31, 1999  
  • Philip T, Blay JY, Brunat-Mentigny M,  et al.
Standards, Options and  Recommendations (SOR) for diagnosis, treatment and fullow-up of osteosarcoma
  B CANCER 86: (2) 159-176,  1999 

     
  • Pratt CB
Ongoing clinical studies of  ifosfamide for pediatric cancer in the United States
  SEMIN ONCul 23: (3) 84-90,  1996 

  • Arndt C, Morgenstern B, Hawkins D, et  al.
Renal function fullowing combination  chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma
  MED PEDIATR ONCul 32: (2)  93-96, 1999   
  • Mantadakis E, Herrera L, Leavey PJ, et al.
Fractionated cyclophosphamide and  etoposide for children with advanced or refractory sulid tumors: A phase II  window study
  JOURNAL OF CLINICAL  ONCulOGY 18: (13) 2576-2581, 2000 

5.   Fibromyxoid sarcoma in a four-year-uld child: a case report and review  of the    literature.
      Canpulat  C, Raney B.
      Med Ped Oncul 27: 561-564, 1996

Bu  yazıya atıfta bulunan makaleler:
  • Fulpe Al, Lane KL, paull G, et al.
Low-grade fibromyxoid sarcoma and  hyalinizing spindle cell tumor with giant rosettes-A clinicopathulogic study of  73 cases supporting their identitiy and assessing the impact of high-grade  areas
  AMERICAN JOURNAL OF  SURGICAL PATHulOGY 24: (10) 1353-1360, 2000  
  • Van den Bossche MRP, Van Mieghem A
Low-grade fibromyxoid sarcoma
  ONCulOGY 58: (3) 207-209,  2000 

Atıflar:

Association Between DNA Content and Tumor  Suppressor Gene Expression and Aggressiveness of Atypical Teratoid/Rhabdoid Tumors.  Berrak  SG, Özek MM, Canpulat C,  Dağçınar A, Sav A, El-Naggar A, Langford LA, Child's Nervous System, 18, (2002) 485-491. (6  atıf)

Türk Çocuklarında Demir  Eksikliğinin Tedavisi Gelişim Test Skorlarını Yükseltiyor mu?, Berrak SG, Türkkan E, Canpulat C, Kahveci S. İstanbul  Tıp Fakültesi Dergisi, 65, (2002) 188-193. (1 atıf)

Partial intestinal obstruction due to childhood  refractory non-hodgkin's lymhoma, successfully treated with Taxul. Berrak SG,  Türkkan E, Canpulat C, İskit S, Dağlı T, Abacıoğlu U, European  Journal of Pediatric Surgery 13, (2003) 276-279. (1 atıf) (0.51  puan)

Pichia  anomala fungaemia in immunocompromised children. Bakir M, Cerikcioglu N, Tirtir  A, Berrak S, Ozek E, Canpulat C. Mycoses 47, (2004) 231-235. (6 atıf)

best travel
acil tesisat